Integration of Hi-C with short and long-read genome sequencing reveals the structure of germline rearranged genomes.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
29 10 2022
Historique:
received: 17 10 2021
accepted: 07 10 2022
pubmed: 31 10 2022
medline: 2 11 2022
entrez: 30 10 2022
Statut: epublish

Résumé

Structural variants are a common cause of disease and contribute to a large extent to inter-individual variability, but their detection and interpretation remain a challenge. Here, we investigate 11 individuals with complex genomic rearrangements including germline chromothripsis by combining short- and long-read genome sequencing (GS) with Hi-C. Large-scale genomic rearrangements are identified in Hi-C interaction maps, allowing for an independent assessment of breakpoint calls derived from the GS methods, resulting in >300 genomic junctions. Based on a comprehensive breakpoint detection and Hi-C, we achieve a reconstruction of whole rearranged chromosomes. Integrating information on the three-dimensional organization of chromatin, we observe that breakpoints occur more frequently than expected in lamina-associated domains (LADs) and that a majority reshuffle topologically associating domains (TADs). By applying phased RNA-seq, we observe an enrichment of genes showing allelic imbalanced expression (AIG) within 100 kb around the breakpoints. Interestingly, the AIGs hit by a breakpoint (19/22) display both up- and downregulation, thereby suggesting different mechanisms at play, such as gene disruption and rearrangements of regulatory information. However, the majority of interpretable genes located 200 kb around a breakpoint do not show significant expression changes. Thus, there is an overall robustness in the genome towards large-scale chromosome rearrangements.

Identifiants

pubmed: 36309531
doi: 10.1038/s41467-022-34053-7
pii: 10.1038/s41467-022-34053-7
pmc: PMC9617858
doi:

Substances chimiques

Chromatin 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

6470

Informations de copyright

© 2022. The Author(s).

Références

J Med Genet. 2001 Feb;38(2):117-21
pubmed: 11288711
Nucleic Acids Res. 2004 Jan 1;32(Database issue):D493-6
pubmed: 14681465
Cell Syst. 2016 Jul;3(1):99-101
pubmed: 27467250
Genome Res. 2017 Jul;27(7):1126-1138
pubmed: 28424353
Genome Res. 2002 Jun;12(6):996-1006
pubmed: 12045153
Nat Biotechnol. 2011 Jan;29(1):24-6
pubmed: 21221095
Nat Genet. 2019 Aug;51(8):1263-1271
pubmed: 31358994
Cancer Cell. 2013 May 13;23(5):567-9
pubmed: 23680143
Bioinformatics. 2012 Sep 15;28(18):i333-i339
pubmed: 22962449
Am J Hum Genet. 2019 Apr 4;104(4):565-577
pubmed: 30951674
Science. 2009 Oct 9;326(5950):289-93
pubmed: 19815776
Genome Res. 2017 May;27(5):801-812
pubmed: 27940952
PLoS Comput Biol. 2013;9(8):e1003118
pubmed: 23950696
Cell. 2017 Oct 5;171(2):305-320.e24
pubmed: 28985562
Nat Genet. 2018 Oct;50(10):1388-1398
pubmed: 30202056
Cell. 2014 Dec 18;159(7):1665-80
pubmed: 25497547
Cell Syst. 2016 Jul;3(1):95-8
pubmed: 27467249
Science. 2017 Apr 7;356(6333):92-95
pubmed: 28336562
Genome Res. 2016 Nov;26(11):1453-1467
pubmed: 27803192
Mol Cell. 2019 Jun 20;74(6):1110-1122
pubmed: 31226276
Am J Hum Genet. 2020 Jun 4;106(6):872-884
pubmed: 32470376
Bioinformatics. 2010 Mar 1;26(5):589-95
pubmed: 20080505
Nat Commun. 2014 Dec 17;5:5695
pubmed: 25517223
Genome Res. 2021 Mar;31(3):448-460
pubmed: 33441414
Nature. 2016 Oct 13;538(7624):265-269
pubmed: 27706140
Nat Genet. 2017 Jan;49(1):65-74
pubmed: 27869826
Genome Biol. 2014;15(12):550
pubmed: 25516281
Cell Rep. 2012 Jun 28;1(6):648-55
pubmed: 22813740
Cell. 2015 May 21;161(5):1012-1025
pubmed: 25959774
Genome Res. 2022 Apr;32(4):643-655
pubmed: 35177558
Nat Methods. 2021 Jun;18(6):661-668
pubmed: 34092790
Nature. 2020 Feb;578(7793):82-93
pubmed: 32025007
Bioinformatics. 2019 Sep 1;35(17):2907-2915
pubmed: 30668829
Nat Genet. 2019 Aug;51(8):1272-1282
pubmed: 31308546
J Comput Biol. 2015 Jun;22(6):498-509
pubmed: 25658651
Bioinformatics. 2014 Oct;30(19):2811-2
pubmed: 24930139
Gigascience. 2021 Feb 16;10(2):
pubmed: 33590861
Hum Mutat. 2019 Aug;40(8):1057-1062
pubmed: 31033088
Trends Genet. 2013 Oct;29(10):569-74
pubmed: 23810203
Nature. 2008 Jun 12;453(7197):948-51
pubmed: 18463634
Nat Genet. 2010 Nov;42(11):1021-6
pubmed: 20890276
Cell. 2017 May 18;169(5):930-944.e22
pubmed: 28525758
Nature. 2020 May;581(7809):444-451
pubmed: 32461652
Trends Genet. 2014 Mar;30(3):85-94
pubmed: 24503142
Nat Genet. 2020 Mar;52(3):331-341
pubmed: 32025003
Genome Biol. 2018 Oct 4;19(1):151
pubmed: 30286773
Eur J Pediatr. 2003 Sep;162(9):582-8
pubmed: 12819962
Bioinformatics. 2014 Sep 1;30(17):2503-5
pubmed: 24812344
Bioinformatics. 2013 Jan 1;29(1):15-21
pubmed: 23104886
Nat Rev Genet. 2018 Jul;19(7):453-467
pubmed: 29692413
Science. 2021 Apr 2;372(6537):
pubmed: 33632895
Nat Commun. 2019 Apr 16;10(1):1784
pubmed: 30992455
Nat Biotechnol. 2013 Dec;31(12):1143-7
pubmed: 24270850
BMC Biol. 2018 Aug 7;16(1):87
pubmed: 30086749

Auteurs

Robert Schöpflin (R)

Max Planck Institute for Molecular Genetics, RG Development & Disease, Berlin, Germany.
Institute for Medical and Human Genetics, Charité Universitätsmedizin Berlin, Berlin, Germany.
Max Planck Institute for Molecular Genetics, Department of Computational Molecular Biology, Berlin, Germany.

Uirá Souto Melo (US)

Max Planck Institute for Molecular Genetics, RG Development & Disease, Berlin, Germany.
Institute for Medical and Human Genetics, Charité Universitätsmedizin Berlin, Berlin, Germany.

Hossein Moeinzadeh (H)

Max Planck Institute for Molecular Genetics, Department of Computational Molecular Biology, Berlin, Germany.

David Heller (D)

Max Planck Institute for Molecular Genetics, Department of Computational Molecular Biology, Berlin, Germany.

Verena Laupert (V)

Max Planck Institute for Molecular Genetics, Department of Computational Molecular Biology, Berlin, Germany.

Jakob Hertzberg (J)

Max Planck Institute for Molecular Genetics, RG Development & Disease, Berlin, Germany.
Institute for Medical and Human Genetics, Charité Universitätsmedizin Berlin, Berlin, Germany.
Max Planck Institute for Molecular Genetics, Department of Computational Molecular Biology, Berlin, Germany.

Manuel Holtgrewe (M)

CUBI-Core Unit Bioinformatics, Berlin Institute of Health, Berlin, Germany.
Charité-University Medicine Berlin, Berlin, Germany.

Nico Alavi (N)

Max Planck Institute for Molecular Genetics, Department of Computational Molecular Biology, Berlin, Germany.

Marius-Konstantin Klever (MK)

Max Planck Institute for Molecular Genetics, RG Development & Disease, Berlin, Germany.
Institute for Medical and Human Genetics, Charité Universitätsmedizin Berlin, Berlin, Germany.

Julius Jungnitsch (J)

Max Planck Institute for Molecular Genetics, RG Development & Disease, Berlin, Germany.
Institute for Medical and Human Genetics, Charité Universitätsmedizin Berlin, Berlin, Germany.

Emel Comak (E)

Max Planck Institute for Molecular Genetics, Department of Computational Molecular Biology, Berlin, Germany.

Seval Türkmen (S)

Institute for Medical and Human Genetics, Charité Universitätsmedizin Berlin, Berlin, Germany.
Laboratoire national de santé, Dudelange, Luxembourg.

Denise Horn (D)

Institute for Medical and Human Genetics, Charité Universitätsmedizin Berlin, Berlin, Germany.

Yannis Duffourd (Y)

UFR Des Sciences de Santé, INSERM-Université de Bourgogne UMR1231 GAD « Génétique des Anomalies du Développement », FHU-TRANSLAD, Dijon, France.
Unité Fonctionnelle d'Innovation diagnostique des maladies rares, FHU-TRANSLAD, CHU Dijon Bourgogne, Dijon, France.

Laurence Faivre (L)

UFR Des Sciences de Santé, INSERM-Université de Bourgogne UMR1231 GAD « Génétique des Anomalies du Développement », FHU-TRANSLAD, Dijon, France.
Department of Genetics and Centres of Reference for rare disorders, developmental abnormalities and intellectual disabilities, FHU TRANSLAD and GIMI Institute, University Hospital Dijon, Dijon, France.

Patrick Callier (P)

UFR Des Sciences de Santé, INSERM-Université de Bourgogne UMR1231 GAD « Génétique des Anomalies du Développement », FHU-TRANSLAD, Dijon, France.
Unité Fonctionnelle d'Innovation diagnostique des maladies rares, FHU-TRANSLAD, CHU Dijon Bourgogne, Dijon, France.

Damien Sanlaville (D)

Department of Medical Genetics, University Hospital of Lyon, 69007, Lyon, France.

Orsetta Zuffardi (O)

Medical Genetics, Department of Molecular Medicine, University of Pavia, Pavia, Italy.

Romano Tenconi (R)

Genetica Clinica, Dipartimento di Pediatria, Università di Padova, Padova, Italy.

Nehir Edibe Kurtas (NE)

Medical Genetics Unit, Meyer Children's University Hospital, Florence, Italy.

Sabrina Giglio (S)

Medical Genetics Unit, University of Cagliari, Cagliari, Italy.

Bettina Prager (B)

Praxis für Humangenetik, Kinderzentrum Dresden-Friedrichstadt, Dresden, Germany.

Anna Latos-Bielenska (A)

Department of Medical Genetics, University of Medical Sciences in Poznan, Poznan, Poland.

Ida Vogel (I)

Department for Clinical Medicine, Aarhus University, Aarhus, Denmark.

Merete Bugge (M)

Wilhelm Johannsen Center for Functional Genome Research, Department of Cellular and Molecular Medicine, University of Copenhagen, Copenhagen, Denmark.

Niels Tommerup (N)

Wilhelm Johannsen Center for Functional Genome Research, Department of Cellular and Molecular Medicine, University of Copenhagen, Copenhagen, Denmark.

Malte Spielmann (M)

Max Planck Institute for Molecular Genetics, RG Development & Disease, Berlin, Germany.
Institute of Human Genetics, University Hospitals Schleswig-Holstein, University of Lübeck and Kiel University, 23562 Lübeck, 24105, Kiel, Germany.
DZHK (German Centre for Cardiovascular Research), partner site Hamburg/Lübeck/Kiel, 23562, Lübeck, Germany.

Antonio Vitobello (A)

UFR Des Sciences de Santé, INSERM-Université de Bourgogne UMR1231 GAD « Génétique des Anomalies du Développement », FHU-TRANSLAD, Dijon, France.
Unité Fonctionnelle d'Innovation diagnostique des maladies rares, FHU-TRANSLAD, CHU Dijon Bourgogne, Dijon, France.

Vera M Kalscheuer (VM)

Max Planck Institute for Molecular Genetics, RG Development & Disease, Berlin, Germany.

Martin Vingron (M)

Max Planck Institute for Molecular Genetics, Department of Computational Molecular Biology, Berlin, Germany. vingron@molgen.mpg.de.

Stefan Mundlos (S)

Max Planck Institute for Molecular Genetics, RG Development & Disease, Berlin, Germany. stefan.mundlos@charite.de.
Institute for Medical and Human Genetics, Charité Universitätsmedizin Berlin, Berlin, Germany. stefan.mundlos@charite.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH